Form 4: Insmed Executive S. Nicole Schaeffer Reports Stock Transactions

S. Nicole Schaeffer, Chief People Strategy Officer at Insmed Inc., reports the exercise of stock options and sale of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• On June 3, 2024, S. Nicole Schaeffer, Chief People Strategy Officer of Insmed Inc., executed transactions involving Insmed's common stock.
• Schaeffer exercised stock options to acquire 13,750 shares at $16.07 and 41,250 shares at $22.76.
• Concurrently, Schaeffer sold 55,000 shares of common stock at a weighted average price of $55.33, with prices ranging from $54.69 to $55.65.
• These transactions were conducted under a pre-arranged 10b5-1 trading plan.
• Following these transactions, Schaeffer directly owns 108,760 shares of Insmed common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports transactions executed under a pre-existing trading plan. There's no indication of positive or negative sentiment towards the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects. The use of a 10b5-1 trading plan suggests the transactions were pre-planned to avoid accusations of insider trading.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a key executive.
• The impact on employees, customers, suppliers, and creditors is likely negligible.

Key Dates